Retour sur lavenir.net
   KBC 121.600 € (+1,76 %)     ARGENX SE 756.400 € (+0,37 %)     TEXAF 41.000 € (+0,99 %)     LOTUS BAKERIES 10 820.000 € (-1,28 %)     VAN DE VELDE 29.700 € (-1,66 %)     SOFINA 228.400 € (+0,09 %)     AB INBEV 71.880 € (+0,98 %)     MELEXIS 70.100 € (+1,52 %)     UCB 241.400 € (+1,43 %)     XIOR 27.900 € (-0,71 %)     ACKERMANS V.HAAREN 270.400 € (+1,05 %)     WDP 22.280 € (-0,54 %)     RECTICEL 12.020 € (+4,16 %)     ONWARD MEDICAL 2.460 € (+0,20 %)     SOLVAY 25.700 € (-0,39 %)     TUBIZE-FIN 207.600 € (+1,96 %)     UMICORE 19.490 € (+0,98 %)     JENSEN-GROUP 84.800 € (+1,44 %)     AEDIFICA 70.100 € (-0,43 %)     KBC ANCORA 86.400 € (+1,77 %)     KINEPOLIS GROUP 38.700 € (-0,26 %)     ONTEX GROUP 2.230 € (-1,98 %)     ELIA GROUP 139.200 € (+0,07 %)     TITAN S.A. 49.020 € (+1,79 %)     BARCO 7.805 € (+0,32 %)     PROXIMUS 6.080 € (-0,82 %)     CMB.TECH 13.320 € (-0,30 %)     GBL 77.200 € (+0,13 %)     AGEAS 71.200 € (+0,14 %)     AZELIS GROUP 10.340 € (-2,36 %)     RETAIL ESTATES 68.300 € (+0,15 %)     SYENSQO 68.700 € (-0,65 %)     NYRSTAR 0.062 € (+3,33 %)     D'IETEREN GROUP 174.400 € (-1,91 %)     COLRUYT 38.080 € (-1,50 %)     FAGRON 23.800 € (+0,21 %)     VGP 81.100 € (+1,37 %)     BEKAERT 41.100 € (+0,24 %)     TESSENDERLO 20.600 € (-0,48 %)     VASTNED 29.550 € (0,00 %)     MONTEA 68.300 € (-0,15 %)     OXURION 0.002 € (-7,69 %)     NEWTREE 2.100 € (-7,08 %)     AGFA-GEVAERT 0.380 € (-0,13 %)     FLUXYS BELGIUM D 19.800 € (+2,06 %)     GIMV 44.550 € (+0,11 %)     DEME GROUP 170.000 € (+0,35 %)     SHURGARD 25.550 € (-2,11 %)     QRF 10.100 € (0,00 %)     EKOPAK 3.775 € (-5,63 %)     SIPEF 93.900 € (+1,62 %)     WAREHOUSES ESTATES 39.200 € (+0,51 %)     ABO GROUP 3.900 € (+5,41 %)     WERELDHAVE BELGIUM 52.400 € (0,00 %)     CFE 11.450 € (+1,33 %)     BANQUP GROUP 2.030 € (-3,33 %)     IEP INVEST 4.700 € (0,00 %)     IBA 16.920 € (+0,71 %)     TINC 11.180 € (+0,36 %)     BREDERODE 103.400 € (+0,39 %)  
   PLANISWARE 19.640 € (-5,80 %)     TONNER DRONES 0.027 € (-2,55 %)     EXOSENS 60.400 € (+2,20 %)     FDJ UNITED 22.860 € (-0,61 %)     CVC CAPITAL 14.100 € (-2,62 %)     VALERIO TX 0.875 € (+5,42 %)     SARTORIUS STED BIO 164.700 € (-8,60 %)     KALRAY 7.890 € (+11,91 %)     OCI 4.070 € (-0,15 %)     ADVICENNE 1.740 € (+21,68 %)     COVIVIO 52.000 € (-1,61 %)     EDP 4.551 € (+0,73 %)     ASML HOLDING 1 573.400 € (+3,46 %)     SOITEC 90.740 € (+5,02 %)     ABIVAX 115.800 € (-1,95 %)     ASM INTERNATIONAL 882.600 € (+3,01 %)     AALBERTS NV 39.900 € (+0,71 %)     DASSAULT AVIATION 285.200 € (+1,13 %)     BOUYGUES 48.080 € (+0,08 %)     CARBIOS 7.460 € (+35,39 %)     THALES 226.300 € (+1,07 %)     AKZO NOBEL 57.180 € (-0,42 %)     STMICROELECTRONICS 56.560 € (+3,00 %)     BNP PARIBAS ACT.A 104.180 € (+0,85 %)     TOTALENERGIES 72.230 € (+1,53 %)     EUROFINS SCIENT. 70.160 € (-1,32 %)     SCHNEIDER ELECTRIC 267.250 € (+0,96 %)     VALEO 13.045 € (+2,27 %)     PHILIPS KON 23.280 € (-1,61 %)     LVMH 484.200 € (-0,54 %)     HEIJMANS KON 97.600 € (+1,30 %)     CELLECTIS 2.390 € (+4,09 %)     MOTA ENGIL 4.578 € (+1,24 %)     NN GROUP 78.660 € (+0,18 %)     EUROPLASMA 0.001 € (+20,00 %)     MEXEDIA 3.025 € (+3,24 %)     AXA 44.740 € (-0,04 %)     EKINOPS 2.630 € (+1,54 %)     ABN AMRO BANK N.V. 37.870 € (+1,15 %)     AIR LIQUIDE 176.230 € (-0,83 %)     INNATE PHARMA 1.536 € (+2,26 %)     ADYEN 813.400 € (-0,95 %)     SHELL PLC 37.920 € (+0,03 %)     SAFRAN 324.500 € (-0,06 %)     ESSILORLUXOTTICA 166.950 € (-0,77 %)     CREDIT AGRICOLE 18.035 € (+0,59 %)     ING GROEP N.V. 28.880 € (+1,48 %)     ARCELORMITTAL SA 57.860 € (-0,65 %)     UMG 18.280 € (-0,92 %)     HEINEKEN 77.060 € (-0,26 %)     CAPGEMINI 89.860 € (-1,88 %)     SAINT GOBAIN 73.860 € (-0,99 %)     AHOLD DEL 35.680 € (-0,83 %)     PROSUS 39.505 € (-1,18 %)     MICHELIN 35.170 € (+0,92 %)     RENAULT 25.800 € (-0,39 %)     AIRBUS 195.040 € (+1,70 %)     L'OREAL 379.850 € (-0,14 %)     HERMES INTL 1 673.000 € (-0,18 %)     DBV TECHNOLOGIES 2.505 € (+0,76 %)  
News Réglementées
20/07/2026 15:00

Amrize to Acquire Rapid Redi-Mix in Dallas-Fort Worth

Amrize Ltd / Key word(s): Mergers & Acquisitions
Amrize to Acquire Rapid Redi-Mix in Dallas-Fort Worth

20.07.2026 / 15:00 CET/CEST


CHICAGO, July 20, 2026 – Amrize (AMRZ) has entered into an agreement to acquire Rapid Redi-Mix LLC, a fast growing concrete producer in the Dallas-Fort Worth metro area. With a network of modern batch plants and mixer fleet, Rapid Redi-Mix brings significant synergies with Amrize’s aggregates operations and cement network in the region.

 

This acquisition strengthens Amrize’s network in the growing Texas market adding to the recently announced production expansion of its Midlothian cement plant and the acquisition of PB Materials, the leading aggregates business in West Texas.

 

Jaime Hill, President of Amrize Building Materials: “We are excited about this highly synergistic acquisition in the growing Dallas-Fort Worth market. Rapid Redi-Mix is a great, entrepreneurial business that complements our strong aggregates and cement operations in the region. We look forward to welcoming their 100 talented teammates to the Amrize family."  

 

Gabe Salmons, Founder and CEO of Rapid Redi-Mix: “We are proud to join the Amrize family and accelerate our next chapter of growth with Amrize’s scale, leading cement and aggregates operations and highly efficient distribution network. We are excited to join a high performing team that shares our commitment for serving our customers as the partner of choice.”

 

About Amrize
Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network, we deliver for our customers in every U.S. state and Canadian province. Our 19,000 teammates uniquely serve every construction market from infrastructure, commercial and residential to new build, repair and refurbishment. Amrize achieved $11.8 billion in revenue in 2025 and is listed on the New York Stock Exchange and the SIX Swiss Exchange. We are ready to build your ambition.  

Learn more at amrize.com

Cautionary Note Regarding Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of, and subject to the safe harbor created by, Section 27A of the Securities Act, Section 21E of the Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those preceded by, followed by or that include the words “will,” “may,” “could,” “would,” “should,” “believes,” “expects,” “forecasts,” “anticipates,” “plans,” “estimates,” “targets,” “projects,” “intends” or similar expressions. Such forward-looking statements include, but are not limited to, statements about the benefits of the proposed transaction between Amrize and Rapid Redi-Mix, including Amrize’s plans, objectives, expectations and intentions. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from historical experience or from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, risks related to the the ability to successfully integrate and operate Rapid Redi-Mix following the closing, the incurrence of higher than expected or unexpected costs associated with or relating to the proposed transaction, the potential disruption of the proposed transaction on Amrize or Rapid Redi-Mix’s businesses and their respective relationships with customers, suppliers and employees, and the ability to realize the expected benefits of the proposed acquisition and other factors which can be found in Amrize’s media releases and Amrize’s filings with the SEC. Any forward-looking statement speaks only as of the date on which it is made. The forward-looking statements made in this press release are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events as at such dates, even if they are subsequently made available by Amrize on its website or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements, and we do not undertake or assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

 
Media Relations: media@amrize.com

Investor Relations: investors@amrize.com



End of Media Release
View original content: EQS News


Language:English
Company:Amrize Ltd
Grafenauweg 8
6300 Zug
Switzerland
Phone:+1 773-676-4981
E-mail:media@amrize.com
Internet:www.amrize.com
ISIN:CH1430134226
Listed:SIX Swiss Exchange
EQS News ID:2368568

 
End of NewsEQS News Service

2368568  20.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière